On Thursday, October 3, 2024, Solve M.E. will host a free educational webinar featuring Assistant Professor Rob Wüst from the Vrije Universiteit (Amsterdam, Netherlands), who will discuss skeletal muscle fatigue […]
ME/CFS has a broad spectrum of severity, with some able to work while others require total care and support. People living with Severe ME are often confined to their beds […]
Please join us for the final, culminating webinar of the Infection-Associated Chronic Conditions Understanding and Engagement (ICUE) project, where we will discuss the findings and results from the project as […]
ME/CFS has a broad spectrum of severity, with some able to work while others require total care and support. People living with Severe ME are often confined to their beds […]
ME/CFS has a broad spectrum of severity, with some able to work while others require total care and support. People living with Severe ME are often confined to their beds […]
**NEW TIME AND DATE!** In 2021 the National Institutes of Health (NIH) launched the RECOVER Initiative, a patient-centered, integrated, adaptive research network created to study Long Covid. Included in the […]
**NEW DATE: Tuesday, January 21 @ 10 am PT** ME/CFS has a broad spectrum of severity, with some able to work while others require total care and support. People living […]
Join us for a webinar on April 29 from 3-4 pm PT / 6-7 pm ET with Solve Ramsay Research Grant winners Liisa K. Selin, MD, PhD, and Anna Gil, […]
One of the cornerstones of our annual Advocacy Week program is the EmPOWER M.E. roundtable. Panels of patient advocates, professionals, and scientists share their expertise on topics relevant to the […]
In this webinar, we’ll be joined by panelists Michael Peluso, MD (Assistant Professor of Medicine, University of California, San Francisco) Ezra Spier (Creator, Long Covid Studies), Penelope Markham, PhD (Senior […]
Dr. Akiko Iwasaki (Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University) is the first recipient of Solve’s ME/CFS Catalyst Award in support of her study, […]
Simmaron Research is the second recipient of Solve’s ME/CFS Catalyst Award in support of its study,” “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” Read a preprint […]
